NEW YORK – Global law firm Reed Smith announced that it has advised Bioventus Inc. in connection with the divestiture of its wound business, including the skin substitutes TheraSkin and TheraGenesis, to LifeNet Health. Bioventus is a global leader in innovations for active healing. LifeNet Health, a Virginia Beach-based non-profit, is a global leader in regenerative medicine and life sciences. Prior to the sale, LifeNet Health served as Bioventus’s supplier of the TheraSkin product.
genetic code

The Reed Smith team advising Bioventus included corporate partners Mark Pedretti, Seth Merl, Jennifer Cheng, and Herb Kozlov; life sciences and healthcare partner Scot Hasselman and counsel Sung Park; intellectual property partner Peter Emmi; executive compensation and labor & employment partners Ian Sherwin and Mark Goldstein and counsel Alexandra Manfredi; tax partners James Tandler, Angelo Ciavarella and Mike Jacobs; antitrust partners Michelle Mantine, Isabelle Rahman; and capital markets partner Wendy Grasso; and associates Lan Deng, Leah Hungerman, Jenna Johnston, Luke Meyerson, Charles Sauvage, Russell Schneider, and Shannon Traylor.

A copy of the press release issued by Bioventus can be found on